Shopping Cart
- Remove All
- Your shopping cart is currently empty
Thalidomide-NH-C8-NH2 is a synthetic conjugate comprising an E3 ligase ligand-linker, which merges a cereblon ligand derived from Thalidomide with a specific linker used in PROTAC technology.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.444 € | Backorder |
Description | Thalidomide-NH-C8-NH2 is a synthetic conjugate comprising an E3 ligase ligand-linker, which merges a cereblon ligand derived from Thalidomide with a specific linker used in PROTAC technology. |
In vitro | PROTACs consist of two ligands connected by a linker: one binds to an E3 ubiquitin ligase and the other to a target protein, utilizing the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
Alias | Thalidomide-NH-C8-NH2 |
Molecular Weight | 400.479 |
Formula | C21H28N4O4 |
Cas No. | 1957236-36-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.